Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Elevated serum direct bilirubin is predictive of a poor prognosis for primary myelodysplastic syndrome.

BMC cancer - 12 Nov 2024

Chen Ying, Zhou Danqing, Ma Chao, Cao Jie, Ying Qiming, Sheng Lixia, Yan Xiao, Ouyang Guifang, Mu Qitian

Abstract excerpt

BACKGROUND: The aim of this study was to assess the prognostic significance of serum direct bilirubin (DBIL) for patients newly diagnosed with myelodysplastic syndromes (MDS). METHODS: The clinical, laboratory, and follow-up data of MDS patients were collected, and the associations of DBIL levels with overall survival (OS) and leukemia-free survival (LFS) were analyzed. RESULT: In total, 262 MDS patients were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Bilirubin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Nomograms

Share to Prognosis

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 39533230
DOI: 10.1186/s12885-024-13164-y
PMCID: PMC11559105

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Elevated serum direct bilirubin is predictive of a poor prognosis for primary myelodysplastic syndrome.PMID 39533230Read ↗

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.Semantic proximity Read ↗

[Clinical features of SF3B1 mutation in patients with myelodysplastic syndrome with excess blasts].Semantic proximity Read ↗

Construction and experimental validation of a novel ferroptosis‐related gene signature for myelodysplastic syndromesSemantic proximity Read ↗

Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone.Semantic proximity Read ↗

Distinctive Molecular Risk Factors Between MDS and MDS/AML Defined by ICC.Semantic proximity Read ↗

Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis.Semantic proximity Read ↗

A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS.Semantic proximity Read ↗

Telomere integrated scoring system of myelodysplastic syndrome.Semantic proximity Read ↗

Prognostic value of isocitrate dehydrogenase mutations in myelodysplastic syndromes: a retrospective cohort study and meta-analysis.Semantic proximity Read ↗

Significance of SF3B1 Mutations in Myeloid Neoplasms.Semantic proximity Read ↗

Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.Semantic proximity Read ↗

Research progress on ferroptosis in Myelodysplastic syndromesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.